AVAH vs. HCAT

Last updated Apr 1, 2026

Compare and contrast key facts about Aveanna Healthcare Holdings Inc. (AVAH) and Health Catalyst, Inc. (HCAT).

Performance

AVAH vs. HCAT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Aveanna Healthcare Holdings Inc. (AVAH) and Health Catalyst, Inc. (HCAT). The values are adjusted to include any dividend payments, if applicable.

AVAH vs. HCAT - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
AVAH Aveanna Healthcare Holdings Inc.	-21.18%	78.77%	70.52%	243.59%	-89.46%	-38.33%
HCAT Health Catalyst, Inc.	-46.86%	-66.20%	-23.65%	-12.89%	-73.17%	-30.00%

Fundamentals

Market Cap AVAH : $1.38B HCAT : $90.17M
EPS AVAH : $1.04 HCAT : -$2.53
PS Ratio AVAH : 0.57 HCAT : 0.29
PB Ratio AVAH : 7.12 HCAT : 0.37
Total Revenue (TTM) AVAH : $2.43B HCAT : $311.14M
Gross Profit (TTM) AVAH : $810.48M HCAT : $151.68M
EBITDA (TTM) AVAH : $213.57M HCAT : -$112.59M

Returns By Period

In the year-to-date period, AVAH achieves a -21.18% return, which is significantly higher than HCAT's -46.86% return.

AVAH

• 1D: 0.94%
• 1M: -12.50%
• YTD: -21.18%
• 6M: -27.40%
• 1Y: 18.82%
• 3Y*: 83.63%
• 5Y*: —
• 10Y*: —

HCAT

• 1D: 7.63%
• 1M: -21.60%
• YTD: -46.86%
• 6M: -55.44%
• 1Y: -71.96%
• 3Y*: -52.26%
• 5Y*: -51.67%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

AVAH vs. HCAT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AVAH

AVAH Risk / Return Rank: 55
AVAH Sharpe Ratio Rank: 52
AVAH Sortino Ratio Rank: 59
AVAH Omega Ratio Rank: 56
AVAH Calmar Ratio Rank: 54
AVAH Martin Ratio Rank: 53

HCAT

HCAT Risk / Return Rank: 4
HCAT Sharpe Ratio Rank: 5
HCAT Sortino Ratio Rank: 3
HCAT Omega Ratio Rank: 5
HCAT Calmar Ratio Rank: 5
HCAT Martin Ratio Rank: 3

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AVAH vs. HCAT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Aveanna Healthcare Holdings Inc. (AVAH) and Health Catalyst, Inc. (HCAT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	AVAH	HCAT	Difference
Sharpe ratio Return per unit of total volatility	0.27	-1.00	+1.27
Sortino ratio Return per unit of downside risk	1.13	-1.82	+2.95
Omega ratio Gain probability vs. loss probability	1.13	0.79	+0.35
Calmar ratio Return relative to maximum drawdown	0.51	-0.95	+1.46
Martin ratio Return relative to average drawdown	1.06	-1.87	+2.93
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

AVAH vs. HCAT - Sharpe Ratio Comparison

The current AVAH Sharpe Ratio is 0.27, which is higher than the HCAT Sharpe Ratio of -1.00. The chart below compares the historical Sharpe Ratios of AVAH and HCAT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	AVAH	HCAT	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.27	-1.00	+1.27
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.78	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.15	-0.62	+0.47

Correlation

The correlation between AVAH and HCAT is 0.29, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

AVAH vs. HCAT - Dividend Comparison

Neither AVAH nor HCAT has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

AVAH vs. HCAT - Drawdown Comparison

The maximum AVAH drawdown since its inception was -94.76%, roughly equal to the maximum HCAT drawdown of -98.13%. Use the drawdown chart below to compare losses from any high point for AVAH and HCAT.

Drawdown Indicators

	AVAH	HCAT	Difference
Max Drawdown Largest peak-to-trough decline	-94.76%	-98.13%	+3.37%
Max Drawdown (1Y) Largest decline over 1 year	-38.75%	-75.77%	+37.02%
Max Drawdown (5Y) Largest decline over 5 years	—	-98.13%	—
Current Drawdown Current decline from peak	-50.04%	-97.83%	+47.79%
Average Drawdown Average peak-to-trough decline	-64.30%	-61.52%	-2.78%
Ulcer Index Depth and duration of drawdowns from previous peaks	18.85%	38.54%	-19.69%

Volatility

AVAH vs. HCAT - Volatility Comparison

The current volatility for Aveanna Healthcare Holdings Inc. (AVAH) is 12.45%, while Health Catalyst, Inc. (HCAT) has a volatility of 38.55%. This indicates that AVAH experiences smaller price fluctuations and is considered to be less risky than HCAT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	AVAH	HCAT	Difference
Volatility (1M) Calculated over the trailing 1-month period	12.45%	38.55%	-26.10%
Volatility (6M) Calculated over the trailing 6-month period	31.69%	55.52%	-23.83%
Volatility (1Y) Calculated over the trailing 1-year period	69.95%	72.21%	-2.26%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	78.47%	66.46%	+12.01%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	78.47%	64.89%	+13.58%

Financials